SCHEMBL19690507

SCHEMBL19690507

C#CCN(Cc1cccc(C(F)(F)F)c1)c1ccc(NC(=O)O)c(N)c1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 1/20 0.55
TYMS P04818 1/20 0.46
KCNQ4 P56696 4/20 0.43
CETP P11597 3/20 0.43
KCNQ5 Q9NR82 3/20 0.43
NR3C1 P04150 1/20 0.42
HDAC6 Q9UBN7 2/20 0.41
PTGES O14684 2/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
DHFR P00374 2/20 0.41
PTGS1 P23219 1/20 0.40
SERPINE1 P05121 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19690353 0.91 KCNQ4 (0.53) KCNQ2TYMSKCNQ4CETPKCNQ5
SCHEMBL19690543 0.90 KCNQ2 (0.62) KCNQ2TYMSKCNQ4KCNQ5NR3C1
SCHEMBL30741272 0.89 KCNQ2 (0.72) KCNQ2TYMSKCNQ4CETPKCNQ5
SCHEMBL19698445 0.89 KCNQ2 (0.72) KCNQ2TYMSKCNQ4CETPKCNQ5
SCHEMBL19690546 0.86 SERPINE1 (0.43) KCNQ2CETPNR3C1HDAC6HDAC11
SCHEMBL19690363 0.83 NR3C1 (0.42) KCNQ2TYMSKCNQ4CETPKCNQ5
SCHEMBL19690439 0.80 KCNQ4 (0.60) KCNQ2TYMSKCNQ4CETPKCNQ5
SCHEMBL19695381 0.80 TYMS (0.42) KCNQ2TYMSCETPHDAC6PTGES
SCHEMBL30741285 0.79 KCNQ2 (0.81) KCNQ2TYMSKCNQ4CETPKCNQ5
SCHEMBL19698444 0.79 KCNQ2 (0.81) KCNQ2TYMSKCNQ4CETPKCNQ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives OCUTERRA THERAPEUTICS, INC. (US) 2024-01-02 US disclosed
US-20210309612-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES OCUTERRA THERAPEUTICS, INC. 2021-10-07 US disclosed
EP-3468947-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SciFluor Life Sciences, Inc. (US) 2019-04-17 EP disclosed
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. 2017-12-14 US disclosed
WO-2017214539-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. (US) 2017-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES KCNQ2, KCNQ1, KCNQ3 KCNQ2 1/4885TYMS 4452/4885KCNQ4 4/4885
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives KCNQ2, KCNQ1, KCNQ3 KCNQ2 1/4885TYMS 4452/4885KCNQ4 4/4885
US-20210309612-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES KCNQ2, KCNQ1, KCNQ3 KCNQ2 1/4885TYMS 4452/4885KCNQ4 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.